95 results
8-K
EX-99.1
OCGN
Ocugen Inc
14 May 24
Ocugen Provides Business Update with First Quarter 2024 Financial Results
3:54pm
Biologics License Application (BLA) and Market Authorization Application (MAA) approval targets
MALVERN, Pa., May 14, 2024 (GLOBE NEWSWIRE) – Ocugen, Inc
8-K
EX-99.1
3sc 2h3yp19x2
8 Nov 22
Other Events
9:12am
8-K
EX-99.3
fh33htjldz2be1d
1 Nov 22
Regulation FD Disclosure
8:15am
8-K
EX-99.2
c5n8jd4b6ob
1 Nov 22
Regulation FD Disclosure
8:15am
8-K
EX-99.1
lrh4x wr0m
26 Aug 22
Other Events
5:04pm
8-K
EX-99.1
rcnz82xbt5r
17 Aug 22
Other Events
4:03pm
8-K
EX-99.1
snqd1nkdgf
16 Aug 22
Other Events
4:09pm
8-K
EX-99.3
dwuhwon
6 May 22
Ocugen Provides Business Update and First Quarter 2022 Financial Results
6:44am
8-K
EX-99.1
7o05dlffu6y o9rt6fr
20 Apr 22
Other Events
5:11pm
8-K
EX-99.1
acv bzklr5h
4 Apr 22
Other Events
5:01pm
8-K
EX-99.1
zwjdih
11 Mar 22
Other Events
4:24pm
8-K
EX-99.1
6ulfjjluszv 7a
22 Feb 22
Other Events
7:39am
8-K
EX-99.1
yute0vwywxl1l ev1r
14 Feb 22
Other Events
5:20pm